A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...

Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...

Ozempic (semaglutide) is a subcutaneous injection used in people with type ... is the most serious warning from the Food and Drug Administration (FDA). For details, see the “Side effects ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was originally approved by the Food and Drug Administration ... Ozempic injection offers not only glycemic control but ...

"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

The phase 3b STEP UP trial in more than 1,400 patients compared a 7.2mg weekly subcutaneous injection of semaglutide to the standard 2.6mg weekly dose sold as Wegovy or a matched placebo.

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...